FDA announces new recalls for Johnson & Johnson & Medtronic | Reviewing a busy year in healthcare advocacy

Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.

There is a risk that these catheters will fail to retain their shape during use, causing procedure delays and creating the risk of an adverse outcome. The FDA first warned users about the issue back in August.

Healthcare policies have rapidly evolved in recent years, and 2025 was no exception. From payment policies to physician shortages, ASE and other medical societies had plenty to fight for throughout the year.

In 2024, a Denver cardiologist was sentenced to 158 years to life in prison for drugging and sexually assaulting multiple women he met through online dating apps. Six of his victims have now filed a civil lawsuit that claims the apps are “hospitable to serial predators.”

Hospitals located in more competitive markets may be more likely to perform TAVR instead of SAVR, according to a new analysis of more than 130,000 patients. Is this a reason for concern?

Cardiology has largely shifted to hospital-employed models, driven by reimbursement compression and evolving physician priorities. This has created challenges as well as opportunities.